Jim Simons Ocugen, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q3 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ocugen, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 290,200 shares of OCGN stock, worth $359,848. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290,200Holding current value
$359,848% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding OCGN
# of Institutions
109Shares Held
64.8MCall Options Held
465KPut Options Held
445K-
Black Rock Inc. New York, NY17.9MShares$22.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$18.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.16MShares$5.16 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA4.15MShares$5.15 Million0.31% of portfolio
-
Geode Capital Management, LLC Boston, MA3.68MShares$4.56 Million0.0% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $269M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...